The two companies today announced a strategic partnership that combines the premium Adheris Health retail pharmacy network and indepth real-world data insights with IPO’s evidence-based behavioral content protocols developed by Duke University Departments of Medicine and Population Health Sciences that covers over 120 diseases and conditions. It also offers additional patient touchpoints to help close the gaps patients may experience across the continuum of care to drive improved health outcomes.
“We are excited to launch this new partnership as it will offer our clients expanded patient engagement options which can be calibrated to unique patient needs and adherence barriers, providing optimized experiences built on proven content and protocol designs. This unique combination will generate superior outcomes for all stakeholders — patients, prescribers, payers and clients,” said John Ciccio, president of Adheris Health.
“This strategic initiative deepens our partnership with Adheris Health through integration and the application of tailored, dynamic behavioral modification solutions to engage, impact and sustain patients and their health outcomes. The ‘one-size-fits-all' approach doesn’t work; patients are complex and unique. Our multi-channel SaaS platform, deep expertise, and proven behavioral protocols manage the complexity for our clients, and tailor engagement to a patient’s uniqueness, driving significantly improved outcomes and high patient retention rates,” said Greg Muffler, CEO of Improved Patient Outcomes.
[Read more: State of the pharmacy 2021: Executive weigh in]